News Express

Highlights from AMA House of Delegates Meeting

December 05, 2025

The AMA’s House of Delegates (HOD) convened in National Harbor, Maryland for its interim meeting in mid-November. The four-day session followed three weeks of preparatory caucus meetings. The House addressed a wide range of timely and pivotal issues shaping the practice of medicine and patient care.

Science News: Physical Medicine and Rehabilitation and Interdisciplinary Spine Clinic Referrals Are Associated With Increased Conversion to Spine Surgery

December 03, 2025

Currently, in the US, many patients receive immediate referral to a spine surgeon upon concern for any spine pathology prior to undergoing conservative management. However, research has demonstrated that referrals to spine surgeons for common problems such as low back pain are often not indicated. This leads to inefficient care, delayed conservative treatments, and longer wait times for available surgical consultations. This study highlights an opportunity to improve efficiency in care for patients and clinicians through proper triaging for spine surgery.

Remembering Jeremy Bland, MB, ChB

November 26, 2025

The AANEM community mourns the passing of Dr. Jeremy Bland, a renowned clinician and researcher whose career spanned nearly 4 decades. Dr. Bland leaves behind an enduring legacy in clinical neurophysiology and carpal tunnel syndrome research.

Science News: Safety and Efficacy of Apitegromab in Nonambulatory Type 2 or Type 3 Spinal Muscular Atrophy (SAPPHIRE): A Phase 3, Double-Blind, Randomised, Placebo-Controlled Trial

November 18, 2025

This article summarizing the results of the SAPHPHIRE trial, a double blind, placebo-controlled, phase 3 clinical trial on the safety and efficacy of apitegromab (myostatin inhibitor) in patients with spinal muscular atrophy (SMA) type 2 and 3.